vers la météo de la validation par utilisateur

Ingenuity307

precedent - 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 - suivant

Phrase 57 - PMID ?

In __SP__ glioma cell lines , U0126 decreases expression of __SP__ __NODE__ mRNA that is increased by agonist monoclonal anti __SP__ __NODE__ protein antibody .


Non annotée
Je ne sais pas
Je n'ai pas trouvé d'analyse satisfaisante


Commentaires :
Analyse 0 
                         +--------------------------------------------------COMP:V-N(In)--------------------------------------------------+                      
                         |               +--------------------------------------------SUBJ:V-N--------------------------------------------+                      
                         |               +-----------------------OBJ:V-N----------------------+                                           |                      
                         |               |          +-----------------SUBJ:V-N----------------+                                           |                      
       +--MOD_ATT:N-ADJ--+               |          +-------COMP:N-N(of)-------+              |                                           |                      
       |      +MOD_ATT:N-+               |          |           +-MOD_ATT:N-ADJ+              |           +--------OBJ:V-N--------+       |                      
       |      |     +MOD_+       +MOD_ATT+          |           |       +MOD_AT+SUBJ:V-N+     +COMP:V-N(by+         +MOD_ATT+SUBJ:+       +OBJ:V-N+              
       |      |     |    |       |       |          |           |       |      |        |     |           |         |       |     |       |       |              
 In __SP__ glioma cell lines , U0126 decreases expression of __SP__ __NODE__ mRNA that is increased by agonist monoclonal anti __SP__ __NODE__ protein antibody .
MOD_ATT:N-ADJ (line,__SP__)
MOD_ATT:N-N (line,glioma)
MOD_ATT:N-N (line,cell)
MOD_ATT:N-N (decrease,U0126)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,mRNA)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,agonist)
MOD_ATT:N-ADJ (anti,monoclonal)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
COMP:V-N(In) (__NODE__,line)
SUBJ:V-N (__NODE__,decrease)
OBJ:V-N (__NODE__,protein)
Analyse 1 
                         +--------------------------------------------------COMP:V-N(In)--------------------------------------------------+                      
                         |               +--------------------------------------------SUBJ:V-N--------------------------------------------+                      
                         |               +-----------------------OBJ:V-N----------------------+                                           |                      
                         |               |          +-----------------SUBJ:V-N----------------+                                           |                      
       +--MOD_ATT:N-ADJ--+               |          +-------COMP:N-N(of)-------+              |                                           |                      
       |      +MOD_ATT:N-+               |          |           +-MOD_ATT:N-ADJ+              |           +--------OBJ:V-N--------+       |                      
       |      |     +MOD_+       +MOD_ATT+          |           |       +MOD_AT+              +COMP:V-N(by+         +MOD_ATT+SUBJ:+       +OBJ:V-N+              
       |      |     |    |       |       |          |           |       |      |              |           |         |       |     |       |       |              
 In __SP__ glioma cell lines , U0126 decreases expression of __SP__ __NODE__ mRNA that is increased by agonist monoclonal anti __SP__ __NODE__ protein antibody .
MOD_ATT:N-ADJ (line,__SP__)
MOD_ATT:N-N (line,glioma)
MOD_ATT:N-N (line,cell)
MOD_ATT:N-N (decrease,U0126)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,agonist)
MOD_ATT:N-ADJ (anti,monoclonal)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
COMP:V-N(In) (__NODE__,line)
SUBJ:V-N (__NODE__,decrease)
OBJ:V-N (__NODE__,protein)
Analyse 2 
                         +--------------------------------------------------COMP:V-N(In)--------------------------------------------------+                      
                         |               +--------------------------------------------SUBJ:V-N--------------------------------------------+                      
                         |               +-----------------------OBJ:V-N----------------------+                                           |                      
                         |               |          +-----------------SUBJ:V-N----------------+                                           |                      
                         |               |          +--------------SUBJ:V-N-------------+     |                                           |                      
       +--MOD_ATT:N-ADJ--+               |          +-------COMP:N-N(of)-------+        |     |                                           |                      
       |      +MOD_ATT:N-+               |          |           +-MOD_ATT:N-ADJ+        |     |           +--------OBJ:V-N--------+       |                      
       |      |     +MOD_+       +MOD_ATT+          |           |       +MOD_AT+        |     +COMP:V-N(by+         +MOD_ATT+SUBJ:+       +OBJ:V-N+              
       |      |     |    |       |       |          |           |       |      |        |     |           |         |       |     |       |       |              
 In __SP__ glioma cell lines , U0126 decreases expression of __SP__ __NODE__ mRNA that is increased by agonist monoclonal anti __SP__ __NODE__ protein antibody .
MOD_ATT:N-ADJ (line,__SP__)
MOD_ATT:N-N (line,glioma)
MOD_ATT:N-N (line,cell)
MOD_ATT:N-N (decrease,U0126)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,expression)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,agonist)
MOD_ATT:N-ADJ (anti,monoclonal)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
COMP:V-N(In) (__NODE__,line)
SUBJ:V-N (__NODE__,decrease)
OBJ:V-N (__NODE__,protein)
Analyse 3 
                         +--------------------------------------------------COMP:V-N(In)--------------------------------------------------+                      
                         |               +--------------------------------------------SUBJ:V-N--------------------------------------------+                      
                         |               +-----------------------OBJ:V-N----------------------+                                           |                      
                         |               |          +-----------------SUBJ:V-N----------------+                                           |                      
       +--MOD_ATT:N-ADJ--+               |          +-------COMP:N-N(of)-------+              |                                           |                      
       |      +MOD_ATT:N-+               |          |           +-MOD_ATT:N-ADJ+              |           +--------OBJ:V-N--------+       |                      
       |      |     +MOD_+       +MOD_ATT+          |           |       +MOD_AT+              +COMP:V-N(by+         +MOD_ATT+SUBJ:+       +OBJ:V-N+              
       |      |     |    |       |       |          |           |       |      |              |           |         |       |     |       |       |              
 In __SP__ glioma cell lines , U0126 decreases expression of __SP__ __NODE__ mRNA that is increased by agonist monoclonal anti __SP__ __NODE__ protein antibody .
MOD_ATT:N-ADJ (line,__SP__)
MOD_ATT:N-N (line,glioma)
MOD_ATT:N-N (line,cell)
MOD_ATT:N-N (decrease,U0126)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,agonist)
MOD_ATT:N-ADJ (anti,monoclonal)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
COMP:V-N(In) (__NODE__,line)
SUBJ:V-N (__NODE__,decrease)
OBJ:V-N (__NODE__,protein)
Analyse 4 
                         +----------------------------------------------COMP:V-N(In)----------------------------------------------+                              
                         |               +----------------------------------------SUBJ:V-N----------------------------------------+                              
                         |               +-----------------------OBJ:V-N----------------------+                                   |                              
                         |               |          +-----------------SUBJ:V-N----------------+                                   |                              
       +--MOD_ATT:N-ADJ--+               |          +-------COMP:N-N(of)-------+              +---------COMP:V-N(by)--------+     |                              
       |      +MOD_ATT:N-+               |          |           +-MOD_ATT:N-ADJ+              |           +---MOD_ATT:N-N---+     +----OBJ:V-N----+              
       |      |     +MOD_+       +MOD_ATT+          |           |       +MOD_AT+SUBJ:V-N+     |           |         +MOD_ATT+     |       +MOD_ATT+              
       |      |     |    |       |       |          |           |       |      |        |     |           |         |       |     |       |       |              
 In __SP__ glioma cell lines , U0126 decreases expression of __SP__ __NODE__ mRNA that is increased by agonist monoclonal anti __SP__ __NODE__ protein antibody .
MOD_ATT:N-ADJ (line,__SP__)
MOD_ATT:N-N (line,glioma)
MOD_ATT:N-N (line,cell)
MOD_ATT:N-N (decrease,U0126)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,mRNA)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,anti)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (anti,monoclonal)
COMP:V-N(In) (__SP__,line)
SUBJ:V-N (__SP__,decrease)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
Analyse 5 
                         +----------------------------------------------COMP:V-N(In)----------------------------------------------+                              
                         |               +----------------------------------------SUBJ:V-N----------------------------------------+                              
                         |               +-----------------------OBJ:V-N----------------------+                                   |                              
                         |               |          +-----------------SUBJ:V-N----------------+                                   |                              
       +--MOD_ATT:N-ADJ--+               |          +-------COMP:N-N(of)-------+              +---------COMP:V-N(by)--------+     |                              
       |      +MOD_ATT:N-+               |          |           +-MOD_ATT:N-ADJ+              |           +---MOD_ATT:N-N---+     +----OBJ:V-N----+              
       |      |     +MOD_+       +MOD_ATT+          |           |       +MOD_AT+              |           |         +MOD_ATT+     |       +MOD_ATT+              
       |      |     |    |       |       |          |           |       |      |              |           |         |       |     |       |       |              
 In __SP__ glioma cell lines , U0126 decreases expression of __SP__ __NODE__ mRNA that is increased by agonist monoclonal anti __SP__ __NODE__ protein antibody .
MOD_ATT:N-ADJ (line,__SP__)
MOD_ATT:N-N (line,glioma)
MOD_ATT:N-N (line,cell)
MOD_ATT:N-N (decrease,U0126)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,anti)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (anti,monoclonal)
COMP:V-N(In) (__SP__,line)
SUBJ:V-N (__SP__,decrease)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
Analyse 6 
                         +--------------------------------------------------COMP:V-N(In)--------------------------------------------------+                      
                         |               +--------------------------------------------SUBJ:V-N--------------------------------------------+                      
                         |               +-----------------------OBJ:V-N----------------------+                                           |                      
                         |               |          +-----------------SUBJ:V-N----------------+------------COMP:V-N(by)-----------+       |                      
       +--MOD_ATT:N-ADJ--+               |          +-------COMP:N-N(of)-------+              |           +------MOD_ATT:N-N------+       |                      
       |      +MOD_ATT:N-+               |          |           +-MOD_ATT:N-ADJ+              |           |         +MOD_ATT:N-ADJ+       |                      
       |      |     +MOD_+       +MOD_ATT+          |           |       +MOD_AT+SUBJ:V-N+     |           |         |       +MOD_A+       +OBJ:V-N+              
       |      |     |    |       |       |          |           |       |      |        |     |           |         |       |     |       |       |              
 In __SP__ glioma cell lines , U0126 decreases expression of __SP__ __NODE__ mRNA that is increased by agonist monoclonal anti __SP__ __NODE__ protein antibody .
MOD_ATT:N-ADJ (line,__SP__)
MOD_ATT:N-N (line,glioma)
MOD_ATT:N-N (line,cell)
MOD_ATT:N-N (decrease,U0126)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,mRNA)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,__SP__)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-ADJ (__SP__,monoclonal)
MOD_ATT:N-N (__SP__,anti)
COMP:V-N(In) (__NODE__,line)
SUBJ:V-N (__NODE__,decrease)
OBJ:V-N (__NODE__,protein)
Analyse 7 
                         +--------------------------------------------------COMP:V-N(In)--------------------------------------------------+                      
                         |               +--------------------------------------------SUBJ:V-N--------------------------------------------+                      
                         |               +-----------------------OBJ:V-N----------------------+                                           |                      
                         |               |          +-----------------SUBJ:V-N----------------+------------COMP:V-N(by)-----------+       |                      
       +--MOD_ATT:N-ADJ--+               |          +-------COMP:N-N(of)-------+              |           +------MOD_ATT:N-N------+       |                      
       |      +MOD_ATT:N-+               |          |           +-MOD_ATT:N-ADJ+              |           |         +MOD_ATT:N-ADJ+       |                      
       |      |     +MOD_+       +MOD_ATT+          |           |       +MOD_AT+              |           |         |       +MOD_A+       +OBJ:V-N+              
       |      |     |    |       |       |          |           |       |      |              |           |         |       |     |       |       |              
 In __SP__ glioma cell lines , U0126 decreases expression of __SP__ __NODE__ mRNA that is increased by agonist monoclonal anti __SP__ __NODE__ protein antibody .
MOD_ATT:N-ADJ (line,__SP__)
MOD_ATT:N-N (line,glioma)
MOD_ATT:N-N (line,cell)
MOD_ATT:N-N (decrease,U0126)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,__SP__)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-ADJ (__SP__,monoclonal)
MOD_ATT:N-N (__SP__,anti)
COMP:V-N(In) (__NODE__,line)
SUBJ:V-N (__NODE__,decrease)
OBJ:V-N (__NODE__,protein)
Analyse 8 
                         +----------------------------------------------COMP:V-N(In)----------------------------------------------+                              
                         |               +----------------------------------------SUBJ:V-N----------------------------------------+                              
                         |               +-----------------------OBJ:V-N----------------------+                                   |                              
                         |               |          +-----------------SUBJ:V-N----------------+                                   |                              
                         |               |          +--------------SUBJ:V-N-------------+     |                                   |                              
       +--MOD_ATT:N-ADJ--+               |          +-------COMP:N-N(of)-------+        |     +---------COMP:V-N(by)--------+     |                              
       |      +MOD_ATT:N-+               |          |           +-MOD_ATT:N-ADJ+        |     |           +---MOD_ATT:N-N---+     +----OBJ:V-N----+              
       |      |     +MOD_+       +MOD_ATT+          |           |       +MOD_AT+        |     |           |         +MOD_ATT+     |       +MOD_ATT+              
       |      |     |    |       |       |          |           |       |      |        |     |           |         |       |     |       |       |              
 In __SP__ glioma cell lines , U0126 decreases expression of __SP__ __NODE__ mRNA that is increased by agonist monoclonal anti __SP__ __NODE__ protein antibody .
MOD_ATT:N-ADJ (line,__SP__)
MOD_ATT:N-N (line,glioma)
MOD_ATT:N-N (line,cell)
MOD_ATT:N-N (decrease,U0126)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,expression)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,anti)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (anti,monoclonal)
COMP:V-N(In) (__SP__,line)
SUBJ:V-N (__SP__,decrease)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
Analyse 9 
                         +----------------------------------------------COMP:V-N(In)----------------------------------------------+                              
                         |               +----------------------------------------SUBJ:V-N----------------------------------------+                              
                         |               +-----------------------OBJ:V-N----------------------+                                   |                              
                         |               |          +-----------------SUBJ:V-N----------------+                                   |                              
       +--MOD_ATT:N-ADJ--+               |          +-------COMP:N-N(of)-------+              +---------COMP:V-N(by)--------+     |                              
       |      +MOD_ATT:N-+               |          |           +-MOD_ATT:N-ADJ+              |           +---MOD_ATT:N-N---+     +----OBJ:V-N----+              
       |      |     +MOD_+       +MOD_ATT+          |           |       +MOD_AT+              |           |         +MOD_ATT+     |       +MOD_ATT+              
       |      |     |    |       |       |          |           |       |      |              |           |         |       |     |       |       |              
 In __SP__ glioma cell lines , U0126 decreases expression of __SP__ __NODE__ mRNA that is increased by agonist monoclonal anti __SP__ __NODE__ protein antibody .
MOD_ATT:N-ADJ (line,__SP__)
MOD_ATT:N-N (line,glioma)
MOD_ATT:N-N (line,cell)
MOD_ATT:N-N (decrease,U0126)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,anti)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (anti,monoclonal)
COMP:V-N(In) (__SP__,line)
SUBJ:V-N (__SP__,decrease)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
Analyse 10 
                         +--------------------------------------------------COMP:V-N(In)--------------------------------------------------+                      
                         |               +--------------------------------------------SUBJ:V-N--------------------------------------------+                      
                         |               +-----------------------OBJ:V-N----------------------+                                           |                      
                         |               |          +-----------------SUBJ:V-N----------------+                                           |                      
                         |               |          +--------------SUBJ:V-N-------------+     +------------COMP:V-N(by)-----------+       |                      
       +--MOD_ATT:N-ADJ--+               |          +-------COMP:N-N(of)-------+        |     |           +------MOD_ATT:N-N------+       |                      
       |      +MOD_ATT:N-+               |          |           +-MOD_ATT:N-ADJ+        |     |           |         +MOD_ATT:N-ADJ+       |                      
       |      |     +MOD_+       +MOD_ATT+          |           |       +MOD_AT+        |     |           |         |       +MOD_A+       +OBJ:V-N+              
       |      |     |    |       |       |          |           |       |      |        |     |           |         |       |     |       |       |              
 In __SP__ glioma cell lines , U0126 decreases expression of __SP__ __NODE__ mRNA that is increased by agonist monoclonal anti __SP__ __NODE__ protein antibody .
MOD_ATT:N-ADJ (line,__SP__)
MOD_ATT:N-N (line,glioma)
MOD_ATT:N-N (line,cell)
MOD_ATT:N-N (decrease,U0126)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,expression)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,__SP__)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-ADJ (__SP__,monoclonal)
MOD_ATT:N-N (__SP__,anti)
COMP:V-N(In) (__NODE__,line)
SUBJ:V-N (__NODE__,decrease)
OBJ:V-N (__NODE__,protein)
Analyse 11 
                         +--------------------------------------------------COMP:V-N(In)--------------------------------------------------+                      
                         |               +--------------------------------------------SUBJ:V-N--------------------------------------------+                      
                         |               +-----------------------OBJ:V-N----------------------+                                           |                      
                         |               |          +-----------------SUBJ:V-N----------------+------------COMP:V-N(by)-----------+       |                      
       +--MOD_ATT:N-ADJ--+               |          +-------COMP:N-N(of)-------+              |           +------MOD_ATT:N-N------+       |                      
       |      +MOD_ATT:N-+               |          |           +-MOD_ATT:N-ADJ+              |           |         +MOD_ATT:N-ADJ+       |                      
       |      |     +MOD_+       +MOD_ATT+          |           |       +MOD_AT+              |           |         |       +MOD_A+       +OBJ:V-N+              
       |      |     |    |       |       |          |           |       |      |              |           |         |       |     |       |       |              
 In __SP__ glioma cell lines , U0126 decreases expression of __SP__ __NODE__ mRNA that is increased by agonist monoclonal anti __SP__ __NODE__ protein antibody .
MOD_ATT:N-ADJ (line,__SP__)
MOD_ATT:N-N (line,glioma)
MOD_ATT:N-N (line,cell)
MOD_ATT:N-N (decrease,U0126)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,__SP__)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-ADJ (__SP__,monoclonal)
MOD_ATT:N-N (__SP__,anti)
COMP:V-N(In) (__NODE__,line)
SUBJ:V-N (__NODE__,decrease)
OBJ:V-N (__NODE__,protein)
Analyse 12 
                         +----------------------------COMP:V-N(In)----------------------------+                                                                  
                         |                          +-----------------SUBJ:V-N----------------+                                                                  
       +--MOD_ATT:N-ADJ--+                          +-------COMP:N-N(of)-------+              +----------------------OBJ:V-N----------------------+              
       |      +MOD_ATT:N-+       +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+              |           +--------OBJ:V-N--------+               |              
       |      |     +MOD_+       |       +MOD_ATT:N-+           |       +MOD_AT+SUBJ:V-N+     +COMP:V-N(by+         +MOD_ATT+SUBJ:+       +MOD_ATT+              
       |      |     |    |       |       |          |           |       |      |        |     |           |         |       |     |       |       |              
 In __SP__ glioma cell lines , U0126 decreases expression of __SP__ __NODE__ mRNA that is increased by agonist monoclonal anti __SP__ __NODE__ protein antibody .
MOD_ATT:N-ADJ (line,__SP__)
MOD_ATT:N-N (line,glioma)
MOD_ATT:N-N (line,cell)
MOD_ATT:N-N (expression,U0126)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,mRNA)
COMP:V-N(In) (increase,line)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,agonist)
OBJ:V-N (increase,protein)
MOD_ATT:N-ADJ (anti,monoclonal)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-ADJ (protein,__NODE__)
Analyse 13 
                         +----------------------------COMP:V-N(In)----------------------------+                                                                  
                         |                          +-----------------SUBJ:V-N----------------+                                                                  
       +--MOD_ATT:N-ADJ--+                          +-------COMP:N-N(of)-------+              +----------------------OBJ:V-N----------------------+              
       |      +MOD_ATT:N-+       +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+              |           +--------OBJ:V-N--------+               |              
       |      |     +MOD_+       |       +MOD_ATT:N-+           |       +MOD_AT+              +COMP:V-N(by+         +MOD_ATT+SUBJ:+       +MOD_ATT+              
       |      |     |    |       |       |          |           |       |      |              |           |         |       |     |       |       |              
 In __SP__ glioma cell lines , U0126 decreases expression of __SP__ __NODE__ mRNA that is increased by agonist monoclonal anti __SP__ __NODE__ protein antibody .
MOD_ATT:N-ADJ (line,__SP__)
MOD_ATT:N-N (line,glioma)
MOD_ATT:N-N (line,cell)
MOD_ATT:N-N (expression,U0126)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:V-N(In) (increase,line)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,agonist)
OBJ:V-N (increase,protein)
MOD_ATT:N-ADJ (anti,monoclonal)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-ADJ (protein,__NODE__)
Analyse 14 
                         +----------------------------COMP:V-N(In)----------------------------+                                                                  
                         |                          +-----------------SUBJ:V-N----------------+                                                                  
                         |                          +--------------SUBJ:V-N-------------+     |                                                                  
       +--MOD_ATT:N-ADJ--+                          +-------COMP:N-N(of)-------+        |     +----------------------OBJ:V-N----------------------+              
       |      +MOD_ATT:N-+       +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+        |     |           +--------OBJ:V-N--------+               |              
       |      |     +MOD_+       |       +MOD_ATT:N-+           |       +MOD_AT+        |     +COMP:V-N(by+         +MOD_ATT+SUBJ:+       +MOD_ATT+              
       |      |     |    |       |       |          |           |       |      |        |     |           |         |       |     |       |       |              
 In __SP__ glioma cell lines , U0126 decreases expression of __SP__ __NODE__ mRNA that is increased by agonist monoclonal anti __SP__ __NODE__ protein antibody .
MOD_ATT:N-ADJ (line,__SP__)
MOD_ATT:N-N (line,glioma)
MOD_ATT:N-N (line,cell)
MOD_ATT:N-N (expression,U0126)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,expression)
COMP:V-N(In) (increase,line)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,agonist)
OBJ:V-N (increase,protein)
MOD_ATT:N-ADJ (anti,monoclonal)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-ADJ (protein,__NODE__)
Analyse 15 
                         +----------------------------COMP:V-N(In)----------------------------+                                                                  
                         |                          +-----------------SUBJ:V-N----------------+                                                                  
       +--MOD_ATT:N-ADJ--+                          +-------COMP:N-N(of)-------+              +----------------------OBJ:V-N----------------------+              
       |      +MOD_ATT:N-+       +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+              |           +--------OBJ:V-N--------+               |              
       |      |     +MOD_+       |       +MOD_ATT:N-+           |       +MOD_AT+              +COMP:V-N(by+         +MOD_ATT+SUBJ:+       +MOD_ATT+              
       |      |     |    |       |       |          |           |       |      |              |           |         |       |     |       |       |              
 In __SP__ glioma cell lines , U0126 decreases expression of __SP__ __NODE__ mRNA that is increased by agonist monoclonal anti __SP__ __NODE__ protein antibody .
MOD_ATT:N-ADJ (line,__SP__)
MOD_ATT:N-N (line,glioma)
MOD_ATT:N-N (line,cell)
MOD_ATT:N-N (expression,U0126)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:V-N(In) (increase,line)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,agonist)
OBJ:V-N (increase,protein)
MOD_ATT:N-ADJ (anti,monoclonal)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-ADJ (protein,__NODE__)
Analyse 16 
                         +--------------------------------------------------COMP:V-N(In)--------------------------------------------------+                      
                         |               +--------------------------------------------SUBJ:V-N--------------------------------------------+                      
                         |               +--------------------------COMP:N-N(by)--------------------------+                               |                      
                         |               +-----------------------OBJ:V-N----------------------+           |                               |                      
                         |               |          +-----------------SUBJ:V-N----------------+           |                               |                      
       +--MOD_ATT:N-ADJ--+               |          +-------COMP:N-N(of)-------+              |           |                               |                      
       |      +MOD_ATT:N-+               |          |           +-MOD_ATT:N-ADJ+              |           +--------OBJ:V-N--------+       |                      
       |      |     +MOD_+       +MOD_ATT+          |           |       +MOD_AT+SUBJ:V-N+     |           |         +MOD_ATT+SUBJ:+       +OBJ:V-N+              
       |      |     |    |       |       |          |           |       |      |        |     |           |         |       |     |       |       |              
 In __SP__ glioma cell lines , U0126 decreases expression of __SP__ __NODE__ mRNA that is increased by agonist monoclonal anti __SP__ __NODE__ protein antibody .
MOD_ATT:N-ADJ (line,__SP__)
MOD_ATT:N-N (line,glioma)
MOD_ATT:N-N (line,cell)
MOD_ATT:N-N (decrease,U0126)
COMP:N-N(by) (decrease,agonist)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,mRNA)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,expression)
MOD_ATT:N-ADJ (anti,monoclonal)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
COMP:V-N(In) (__NODE__,line)
SUBJ:V-N (__NODE__,decrease)
OBJ:V-N (__NODE__,protein)
Analyse 17 
                         +--------------------------------------------------COMP:V-N(In)--------------------------------------------------+                      
                         |               +--------------------------------------------SUBJ:V-N--------------------------------------------+                      
                         |               +--------------------------COMP:N-N(by)--------------------------+                               |                      
                         |               +-----------------------OBJ:V-N----------------------+           |                               |                      
                         |               |          +-----------------SUBJ:V-N----------------+           |                               |                      
       +--MOD_ATT:N-ADJ--+               |          +-------COMP:N-N(of)-------+              |           |                               |                      
       |      +MOD_ATT:N-+               |          |           +-MOD_ATT:N-ADJ+              |           +--------OBJ:V-N--------+       |                      
       |      |     +MOD_+       +MOD_ATT+          |           |       +MOD_AT+              |           |         +MOD_ATT+SUBJ:+       +OBJ:V-N+              
       |      |     |    |       |       |          |           |       |      |              |           |         |       |     |       |       |              
 In __SP__ glioma cell lines , U0126 decreases expression of __SP__ __NODE__ mRNA that is increased by agonist monoclonal anti __SP__ __NODE__ protein antibody .
MOD_ATT:N-ADJ (line,__SP__)
MOD_ATT:N-N (line,glioma)
MOD_ATT:N-N (line,cell)
MOD_ATT:N-N (decrease,U0126)
COMP:N-N(by) (decrease,agonist)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,expression)
MOD_ATT:N-ADJ (anti,monoclonal)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
COMP:V-N(In) (__NODE__,line)
SUBJ:V-N (__NODE__,decrease)
OBJ:V-N (__NODE__,protein)
Analyse 18 
                         +--------------------------------------------------COMP:V-N(In)--------------------------------------------------+                      
                         |               +--------------------------------------------SUBJ:V-N--------------------------------------------+                      
                         |               +--------------------------COMP:N-N(by)--------------------------+                               |                      
                         |               +-----------------------OBJ:V-N----------------------+           |                               |                      
                         |               |          +-----------------SUBJ:V-N----------------+           |                               |                      
                         |               |          +--------------SUBJ:V-N-------------+     |           |                               |                      
       +--MOD_ATT:N-ADJ--+               |          +-------COMP:N-N(of)-------+        |     |           |                               |                      
       |      +MOD_ATT:N-+               |          |           +-MOD_ATT:N-ADJ+        |     |           +--------OBJ:V-N--------+       |                      
       |      |     +MOD_+       +MOD_ATT+          |           |       +MOD_AT+        |     |           |         +MOD_ATT+SUBJ:+       +OBJ:V-N+              
       |      |     |    |       |       |          |           |       |      |        |     |           |         |       |     |       |       |              
 In __SP__ glioma cell lines , U0126 decreases expression of __SP__ __NODE__ mRNA that is increased by agonist monoclonal anti __SP__ __NODE__ protein antibody .
MOD_ATT:N-ADJ (line,__SP__)
MOD_ATT:N-N (line,glioma)
MOD_ATT:N-N (line,cell)
MOD_ATT:N-N (decrease,U0126)
COMP:N-N(by) (decrease,agonist)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,expression)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,expression)
MOD_ATT:N-ADJ (anti,monoclonal)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
COMP:V-N(In) (__NODE__,line)
SUBJ:V-N (__NODE__,decrease)
OBJ:V-N (__NODE__,protein)
Analyse 19 
                         +--------------------------------------------------COMP:V-N(In)--------------------------------------------------+                      
                         |               +--------------------------------------------SUBJ:V-N--------------------------------------------+                      
                         |               +--------------------------COMP:N-N(by)--------------------------+                               |                      
                         |               +-----------------------OBJ:V-N----------------------+           |                               |                      
                         |               |          +-----------------SUBJ:V-N----------------+           |                               |                      
       +--MOD_ATT:N-ADJ--+               |          +-------COMP:N-N(of)-------+              |           |                               |                      
       |      +MOD_ATT:N-+               |          |           +-MOD_ATT:N-ADJ+              |           +--------OBJ:V-N--------+       |                      
       |      |     +MOD_+       +MOD_ATT+          |           |       +MOD_AT+              |           |         +MOD_ATT+SUBJ:+       +OBJ:V-N+              
       |      |     |    |       |       |          |           |       |      |              |           |         |       |     |       |       |              
 In __SP__ glioma cell lines , U0126 decreases expression of __SP__ __NODE__ mRNA that is increased by agonist monoclonal anti __SP__ __NODE__ protein antibody .
MOD_ATT:N-ADJ (line,__SP__)
MOD_ATT:N-N (line,glioma)
MOD_ATT:N-N (line,cell)
MOD_ATT:N-N (decrease,U0126)
COMP:N-N(by) (decrease,agonist)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,expression)
MOD_ATT:N-ADJ (anti,monoclonal)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
COMP:V-N(In) (__NODE__,line)
SUBJ:V-N (__NODE__,decrease)
OBJ:V-N (__NODE__,protein)
Analyse 20 
                         +----------------------------COMP:V-N(In)----------------------------+                                                                  
                         |                          +-----------------SUBJ:V-N----------------+----------------------OBJ:V-N----------------------+              
       +--MOD_ATT:N-ADJ--+                          +-------COMP:N-N(of)-------+              +---------COMP:V-N(by)--------+                     |              
       |      +MOD_ATT:N-+       +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+              |           +---MOD_ATT:N-N---+     +-MOD_ATT:N-ADJ-+              
       |      |     +MOD_+       |       +MOD_ATT:N-+           |       +MOD_AT+SUBJ:V-N+     |           |         +MOD_ATT+     |       +MOD_ATT+              
       |      |     |    |       |       |          |           |       |      |        |     |           |         |       |     |       |       |              
 In __SP__ glioma cell lines , U0126 decreases expression of __SP__ __NODE__ mRNA that is increased by agonist monoclonal anti __SP__ __NODE__ protein antibody .
MOD_ATT:N-ADJ (line,__SP__)
MOD_ATT:N-N (line,glioma)
MOD_ATT:N-N (line,cell)
MOD_ATT:N-N (expression,U0126)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,mRNA)
COMP:V-N(In) (increase,line)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,anti)
OBJ:V-N (increase,protein)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (anti,monoclonal)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
Analyse 21 
                         +----------------------------COMP:V-N(In)----------------------------+                                                                  
                         |                          +-----------------SUBJ:V-N----------------+----------------------OBJ:V-N----------------------+              
       +--MOD_ATT:N-ADJ--+                          +-------COMP:N-N(of)-------+              +---------COMP:V-N(by)--------+                     |              
       |      +MOD_ATT:N-+       +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+              |           +---MOD_ATT:N-N---+     +-MOD_ATT:N-ADJ-+              
       |      |     +MOD_+       |       +MOD_ATT:N-+           |       +MOD_AT+              |           |         +MOD_ATT+     |       +MOD_ATT+              
       |      |     |    |       |       |          |           |       |      |              |           |         |       |     |       |       |              
 In __SP__ glioma cell lines , U0126 decreases expression of __SP__ __NODE__ mRNA that is increased by agonist monoclonal anti __SP__ __NODE__ protein antibody .
MOD_ATT:N-ADJ (line,__SP__)
MOD_ATT:N-N (line,glioma)
MOD_ATT:N-N (line,cell)
MOD_ATT:N-N (expression,U0126)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:V-N(In) (increase,line)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,anti)
OBJ:V-N (increase,protein)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (anti,monoclonal)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
Analyse 22 
                         +----------------------------COMP:V-N(In)----------------------------+----------------------OBJ:V-N----------------------+              
                         |                          +-----------------SUBJ:V-N----------------+------------COMP:V-N(by)-----------+               |              
       +--MOD_ATT:N-ADJ--+                          +-------COMP:N-N(of)-------+              |           +------MOD_ATT:N-N------+               |              
       |      +MOD_ATT:N-+       +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+              |           |         +MOD_ATT:N-ADJ+               |              
       |      |     +MOD_+       |       +MOD_ATT:N-+           |       +MOD_AT+SUBJ:V-N+     |           |         |       +MOD_A+       +MOD_ATT+              
       |      |     |    |       |       |          |           |       |      |        |     |           |         |       |     |       |       |              
 In __SP__ glioma cell lines , U0126 decreases expression of __SP__ __NODE__ mRNA that is increased by agonist monoclonal anti __SP__ __NODE__ protein antibody .
MOD_ATT:N-ADJ (line,__SP__)
MOD_ATT:N-N (line,glioma)
MOD_ATT:N-N (line,cell)
MOD_ATT:N-N (expression,U0126)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,mRNA)
COMP:V-N(In) (increase,line)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,__SP__)
OBJ:V-N (increase,protein)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-ADJ (__SP__,monoclonal)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-ADJ (protein,__NODE__)
Analyse 23 
                         +----------------------------COMP:V-N(In)----------------------------+----------------------OBJ:V-N----------------------+              
                         |                          +-----------------SUBJ:V-N----------------+------------COMP:V-N(by)-----------+               |              
       +--MOD_ATT:N-ADJ--+                          +-------COMP:N-N(of)-------+              |           +------MOD_ATT:N-N------+               |              
       |      +MOD_ATT:N-+       +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+              |           |         +MOD_ATT:N-ADJ+               |              
       |      |     +MOD_+       |       +MOD_ATT:N-+           |       +MOD_AT+              |           |         |       +MOD_A+       +MOD_ATT+              
       |      |     |    |       |       |          |           |       |      |              |           |         |       |     |       |       |              
 In __SP__ glioma cell lines , U0126 decreases expression of __SP__ __NODE__ mRNA that is increased by agonist monoclonal anti __SP__ __NODE__ protein antibody .
MOD_ATT:N-ADJ (line,__SP__)
MOD_ATT:N-N (line,glioma)
MOD_ATT:N-N (line,cell)
MOD_ATT:N-N (expression,U0126)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:V-N(In) (increase,line)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,__SP__)
OBJ:V-N (increase,protein)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-ADJ (__SP__,monoclonal)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-ADJ (protein,__NODE__)
Analyse 24 
                         +----------------------------COMP:V-N(In)----------------------------+                                                                  
                         |                          +-----------------SUBJ:V-N----------------+                                                                  
                         |                          +--------------SUBJ:V-N-------------+     +----------------------OBJ:V-N----------------------+              
       +--MOD_ATT:N-ADJ--+                          +-------COMP:N-N(of)-------+        |     +---------COMP:V-N(by)--------+                     |              
       |      +MOD_ATT:N-+       +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+        |     |           +---MOD_ATT:N-N---+     +-MOD_ATT:N-ADJ-+              
       |      |     +MOD_+       |       +MOD_ATT:N-+           |       +MOD_AT+        |     |           |         +MOD_ATT+     |       +MOD_ATT+              
       |      |     |    |       |       |          |           |       |      |        |     |           |         |       |     |       |       |              
 In __SP__ glioma cell lines , U0126 decreases expression of __SP__ __NODE__ mRNA that is increased by agonist monoclonal anti __SP__ __NODE__ protein antibody .
MOD_ATT:N-ADJ (line,__SP__)
MOD_ATT:N-N (line,glioma)
MOD_ATT:N-N (line,cell)
MOD_ATT:N-N (expression,U0126)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,expression)
COMP:V-N(In) (increase,line)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,anti)
OBJ:V-N (increase,protein)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (anti,monoclonal)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
Analyse 25 
                         +----------------------------COMP:V-N(In)----------------------------+                                                                  
                         |                          +-----------------SUBJ:V-N----------------+----------------------OBJ:V-N----------------------+              
       +--MOD_ATT:N-ADJ--+                          +-------COMP:N-N(of)-------+              +---------COMP:V-N(by)--------+                     |              
       |      +MOD_ATT:N-+       +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+              |           +---MOD_ATT:N-N---+     +-MOD_ATT:N-ADJ-+              
       |      |     +MOD_+       |       +MOD_ATT:N-+           |       +MOD_AT+              |           |         +MOD_ATT+     |       +MOD_ATT+              
       |      |     |    |       |       |          |           |       |      |              |           |         |       |     |       |       |              
 In __SP__ glioma cell lines , U0126 decreases expression of __SP__ __NODE__ mRNA that is increased by agonist monoclonal anti __SP__ __NODE__ protein antibody .
MOD_ATT:N-ADJ (line,__SP__)
MOD_ATT:N-N (line,glioma)
MOD_ATT:N-N (line,cell)
MOD_ATT:N-N (expression,U0126)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:V-N(In) (increase,line)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,anti)
OBJ:V-N (increase,protein)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (anti,monoclonal)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
Analyse 26 
                         +----------------------------COMP:V-N(In)----------------------------+                                                                  
                         |                          +-----------------SUBJ:V-N----------------+----------------------OBJ:V-N----------------------+              
                         |                          +--------------SUBJ:V-N-------------+     +------------COMP:V-N(by)-----------+               |              
       +--MOD_ATT:N-ADJ--+                          +-------COMP:N-N(of)-------+        |     |           +------MOD_ATT:N-N------+               |              
       |      +MOD_ATT:N-+       +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+        |     |           |         +MOD_ATT:N-ADJ+               |              
       |      |     +MOD_+       |       +MOD_ATT:N-+           |       +MOD_AT+        |     |           |         |       +MOD_A+       +MOD_ATT+              
       |      |     |    |       |       |          |           |       |      |        |     |           |         |       |     |       |       |              
 In __SP__ glioma cell lines , U0126 decreases expression of __SP__ __NODE__ mRNA that is increased by agonist monoclonal anti __SP__ __NODE__ protein antibody .
MOD_ATT:N-ADJ (line,__SP__)
MOD_ATT:N-N (line,glioma)
MOD_ATT:N-N (line,cell)
MOD_ATT:N-N (expression,U0126)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,expression)
COMP:V-N(In) (increase,line)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,__SP__)
OBJ:V-N (increase,protein)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-ADJ (__SP__,monoclonal)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-ADJ (protein,__NODE__)
Analyse 27 
                         +----------------------------COMP:V-N(In)----------------------------+----------------------OBJ:V-N----------------------+              
                         |                          +-----------------SUBJ:V-N----------------+------------COMP:V-N(by)-----------+               |              
       +--MOD_ATT:N-ADJ--+                          +-------COMP:N-N(of)-------+              |           +------MOD_ATT:N-N------+               |              
       |      +MOD_ATT:N-+       +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+              |           |         +MOD_ATT:N-ADJ+               |              
       |      |     +MOD_+       |       +MOD_ATT:N-+           |       +MOD_AT+              |           |         |       +MOD_A+       +MOD_ATT+              
       |      |     |    |       |       |          |           |       |      |              |           |         |       |     |       |       |              
 In __SP__ glioma cell lines , U0126 decreases expression of __SP__ __NODE__ mRNA that is increased by agonist monoclonal anti __SP__ __NODE__ protein antibody .
MOD_ATT:N-ADJ (line,__SP__)
MOD_ATT:N-N (line,glioma)
MOD_ATT:N-N (line,cell)
MOD_ATT:N-N (expression,U0126)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:V-N(In) (increase,line)
SUBJ:V-N (increase,expression)
COMP:V-N(by) (increase,__SP__)
OBJ:V-N (increase,protein)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-ADJ (__SP__,monoclonal)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-ADJ (protein,__NODE__)
Analyse 28 
                         +----------------------------------------------COMP:V-N(In)----------------------------------------------+                              
                         |               +----------------------------------------SUBJ:V-N----------------------------------------+                              
                         |               +-----------------------------------COMP:N-N(by)-----------------------------------+     |                              
                         |               +-----------------------OBJ:V-N----------------------+                             |     |                              
                         |               |          +-----------------SUBJ:V-N----------------+                             |     |                              
       +--MOD_ATT:N-ADJ--+               |          +-------COMP:N-N(of)-------+              |                             |     |                              
       |      +MOD_ATT:N-+               |          |           +-MOD_ATT:N-ADJ+              |           +---MOD_ATT:N-N---+     +----OBJ:V-N----+              
       |      |     +MOD_+       +MOD_ATT+          |           |       +MOD_AT+SUBJ:V-N+     |           |         +MOD_ATT+     |       +MOD_ATT+              
       |      |     |    |       |       |          |           |       |      |        |     |           |         |       |     |       |       |              
 In __SP__ glioma cell lines , U0126 decreases expression of __SP__ __NODE__ mRNA that is increased by agonist monoclonal anti __SP__ __NODE__ protein antibody .
MOD_ATT:N-ADJ (line,__SP__)
MOD_ATT:N-N (line,glioma)
MOD_ATT:N-N (line,cell)
MOD_ATT:N-N (decrease,U0126)
COMP:N-N(by) (decrease,anti)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,mRNA)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,expression)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (anti,monoclonal)
COMP:V-N(In) (__SP__,line)
SUBJ:V-N (__SP__,decrease)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
Analyse 29 
                         +----------------------------------------------COMP:V-N(In)----------------------------------------------+                              
                         |               +----------------------------------------SUBJ:V-N----------------------------------------+                              
                         |               +-----------------------------------COMP:N-N(by)-----------------------------------+     |                              
                         |               +-----------------------OBJ:V-N----------------------+                             |     |                              
                         |               |          +-----------------SUBJ:V-N----------------+                             |     |                              
       +--MOD_ATT:N-ADJ--+               |          +-------COMP:N-N(of)-------+              |                             |     |                              
       |      +MOD_ATT:N-+               |          |           +-MOD_ATT:N-ADJ+              |           +---MOD_ATT:N-N---+     +----OBJ:V-N----+              
       |      |     +MOD_+       +MOD_ATT+          |           |       +MOD_AT+              |           |         +MOD_ATT+     |       +MOD_ATT+              
       |      |     |    |       |       |          |           |       |      |              |           |         |       |     |       |       |              
 In __SP__ glioma cell lines , U0126 decreases expression of __SP__ __NODE__ mRNA that is increased by agonist monoclonal anti __SP__ __NODE__ protein antibody .
MOD_ATT:N-ADJ (line,__SP__)
MOD_ATT:N-N (line,glioma)
MOD_ATT:N-N (line,cell)
MOD_ATT:N-N (decrease,U0126)
COMP:N-N(by) (decrease,anti)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,expression)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (anti,monoclonal)
COMP:V-N(In) (__SP__,line)
SUBJ:V-N (__SP__,decrease)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
Analyse 30 
                         +--------------------------------------------------COMP:V-N(In)--------------------------------------------------+                      
                         |               +--------------------------------------------SUBJ:V-N--------------------------------------------+                      
                         |               +--------------------------------------COMP:N-N(by)--------------------------------------+       |                      
                         |               +-----------------------OBJ:V-N----------------------+                                   |       |                      
                         |               |          +-----------------SUBJ:V-N----------------+                                   |       |                      
       +--MOD_ATT:N-ADJ--+               |          +-------COMP:N-N(of)-------+              |           +------MOD_ATT:N-N------+       |                      
       |      +MOD_ATT:N-+               |          |           +-MOD_ATT:N-ADJ+              |           |         +MOD_ATT:N-ADJ+       |                      
       |      |     +MOD_+       +MOD_ATT+          |           |       +MOD_AT+SUBJ:V-N+     |           |         |       +MOD_A+       +OBJ:V-N+              
       |      |     |    |       |       |          |           |       |      |        |     |           |         |       |     |       |       |              
 In __SP__ glioma cell lines , U0126 decreases expression of __SP__ __NODE__ mRNA that is increased by agonist monoclonal anti __SP__ __NODE__ protein antibody .
MOD_ATT:N-ADJ (line,__SP__)
MOD_ATT:N-N (line,glioma)
MOD_ATT:N-N (line,cell)
MOD_ATT:N-N (decrease,U0126)
COMP:N-N(by) (decrease,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,mRNA)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,expression)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-ADJ (__SP__,monoclonal)
MOD_ATT:N-N (__SP__,anti)
COMP:V-N(In) (__NODE__,line)
SUBJ:V-N (__NODE__,decrease)
OBJ:V-N (__NODE__,protein)
Analyse 31 
                         +--------------------------------------------------COMP:V-N(In)--------------------------------------------------+                      
                         |               +--------------------------------------------SUBJ:V-N--------------------------------------------+                      
                         |               +--------------------------------------COMP:N-N(by)--------------------------------------+       |                      
                         |               +-----------------------OBJ:V-N----------------------+                                   |       |                      
                         |               |          +-----------------SUBJ:V-N----------------+                                   |       |                      
       +--MOD_ATT:N-ADJ--+               |          +-------COMP:N-N(of)-------+              |           +------MOD_ATT:N-N------+       |                      
       |      +MOD_ATT:N-+               |          |           +-MOD_ATT:N-ADJ+              |           |         +MOD_ATT:N-ADJ+       |                      
       |      |     +MOD_+       +MOD_ATT+          |           |       +MOD_AT+              |           |         |       +MOD_A+       +OBJ:V-N+              
       |      |     |    |       |       |          |           |       |      |              |           |         |       |     |       |       |              
 In __SP__ glioma cell lines , U0126 decreases expression of __SP__ __NODE__ mRNA that is increased by agonist monoclonal anti __SP__ __NODE__ protein antibody .
MOD_ATT:N-ADJ (line,__SP__)
MOD_ATT:N-N (line,glioma)
MOD_ATT:N-N (line,cell)
MOD_ATT:N-N (decrease,U0126)
COMP:N-N(by) (decrease,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,expression)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-ADJ (__SP__,monoclonal)
MOD_ATT:N-N (__SP__,anti)
COMP:V-N(In) (__NODE__,line)
SUBJ:V-N (__NODE__,decrease)
OBJ:V-N (__NODE__,protein)
Analyse 32 
                         +----------------------------------------------COMP:V-N(In)----------------------------------------------+                              
                         |               +----------------------------------------SUBJ:V-N----------------------------------------+                              
                         |               +-----------------------------------COMP:N-N(by)-----------------------------------+     |                              
                         |               +-----------------------OBJ:V-N----------------------+                             |     |                              
                         |               |          +-----------------SUBJ:V-N----------------+                             |     |                              
                         |               |          +--------------SUBJ:V-N-------------+     |                             |     |                              
       +--MOD_ATT:N-ADJ--+               |          +-------COMP:N-N(of)-------+        |     |                             |     |                              
       |      +MOD_ATT:N-+               |          |           +-MOD_ATT:N-ADJ+        |     |           +---MOD_ATT:N-N---+     +----OBJ:V-N----+              
       |      |     +MOD_+       +MOD_ATT+          |           |       +MOD_AT+        |     |           |         +MOD_ATT+     |       +MOD_ATT+              
       |      |     |    |       |       |          |           |       |      |        |     |           |         |       |     |       |       |              
 In __SP__ glioma cell lines , U0126 decreases expression of __SP__ __NODE__ mRNA that is increased by agonist monoclonal anti __SP__ __NODE__ protein antibody .
MOD_ATT:N-ADJ (line,__SP__)
MOD_ATT:N-N (line,glioma)
MOD_ATT:N-N (line,cell)
MOD_ATT:N-N (decrease,U0126)
COMP:N-N(by) (decrease,anti)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,expression)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,expression)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (anti,monoclonal)
COMP:V-N(In) (__SP__,line)
SUBJ:V-N (__SP__,decrease)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
Analyse 33 
                         +----------------------------------------------COMP:V-N(In)----------------------------------------------+                              
                         |               +----------------------------------------SUBJ:V-N----------------------------------------+                              
                         |               +-----------------------------------COMP:N-N(by)-----------------------------------+     |                              
                         |               +-----------------------OBJ:V-N----------------------+                             |     |                              
                         |               |          +-----------------SUBJ:V-N----------------+                             |     |                              
       +--MOD_ATT:N-ADJ--+               |          +-------COMP:N-N(of)-------+              |                             |     |                              
       |      +MOD_ATT:N-+               |          |           +-MOD_ATT:N-ADJ+              |           +---MOD_ATT:N-N---+     +----OBJ:V-N----+              
       |      |     +MOD_+       +MOD_ATT+          |           |       +MOD_AT+              |           |         +MOD_ATT+     |       +MOD_ATT+              
       |      |     |    |       |       |          |           |       |      |              |           |         |       |     |       |       |              
 In __SP__ glioma cell lines , U0126 decreases expression of __SP__ __NODE__ mRNA that is increased by agonist monoclonal anti __SP__ __NODE__ protein antibody .
MOD_ATT:N-ADJ (line,__SP__)
MOD_ATT:N-N (line,glioma)
MOD_ATT:N-N (line,cell)
MOD_ATT:N-N (decrease,U0126)
COMP:N-N(by) (decrease,anti)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,expression)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (anti,monoclonal)
COMP:V-N(In) (__SP__,line)
SUBJ:V-N (__SP__,decrease)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
Analyse 34 
                         +--------------------------------------------------COMP:V-N(In)--------------------------------------------------+                      
                         |               +--------------------------------------------SUBJ:V-N--------------------------------------------+                      
                         |               +--------------------------------------COMP:N-N(by)--------------------------------------+       |                      
                         |               +-----------------------OBJ:V-N----------------------+                                   |       |                      
                         |               |          +-----------------SUBJ:V-N----------------+                                   |       |                      
                         |               |          +--------------SUBJ:V-N-------------+     |                                   |       |                      
       +--MOD_ATT:N-ADJ--+               |          +-------COMP:N-N(of)-------+        |     |           +------MOD_ATT:N-N------+       |                      
       |      +MOD_ATT:N-+               |          |           +-MOD_ATT:N-ADJ+        |     |           |         +MOD_ATT:N-ADJ+       |                      
       |      |     +MOD_+       +MOD_ATT+          |           |       +MOD_AT+        |     |           |         |       +MOD_A+       +OBJ:V-N+              
       |      |     |    |       |       |          |           |       |      |        |     |           |         |       |     |       |       |              
 In __SP__ glioma cell lines , U0126 decreases expression of __SP__ __NODE__ mRNA that is increased by agonist monoclonal anti __SP__ __NODE__ protein antibody .
MOD_ATT:N-ADJ (line,__SP__)
MOD_ATT:N-N (line,glioma)
MOD_ATT:N-N (line,cell)
MOD_ATT:N-N (decrease,U0126)
COMP:N-N(by) (decrease,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V-N (be,expression)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,expression)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-ADJ (__SP__,monoclonal)
MOD_ATT:N-N (__SP__,anti)
COMP:V-N(In) (__NODE__,line)
SUBJ:V-N (__NODE__,decrease)
OBJ:V-N (__NODE__,protein)
Analyse 35 
                         +--------------------------------------------------COMP:V-N(In)--------------------------------------------------+                      
                         |               +--------------------------------------------SUBJ:V-N--------------------------------------------+                      
                         |               +--------------------------------------COMP:N-N(by)--------------------------------------+       |                      
                         |               +-----------------------OBJ:V-N----------------------+                                   |       |                      
                         |               |          +-----------------SUBJ:V-N----------------+                                   |       |                      
       +--MOD_ATT:N-ADJ--+               |          +-------COMP:N-N(of)-------+              |           +------MOD_ATT:N-N------+       |                      
       |      +MOD_ATT:N-+               |          |           +-MOD_ATT:N-ADJ+              |           |         +MOD_ATT:N-ADJ+       |                      
       |      |     +MOD_+       +MOD_ATT+          |           |       +MOD_AT+              |           |         |       +MOD_A+       +OBJ:V-N+              
       |      |     |    |       |       |          |           |       |      |              |           |         |       |     |       |       |              
 In __SP__ glioma cell lines , U0126 decreases expression of __SP__ __NODE__ mRNA that is increased by agonist monoclonal anti __SP__ __NODE__ protein antibody .
MOD_ATT:N-ADJ (line,__SP__)
MOD_ATT:N-N (line,glioma)
MOD_ATT:N-N (line,cell)
MOD_ATT:N-N (decrease,U0126)
COMP:N-N(by) (decrease,__SP__)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,expression)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-ADJ (__SP__,monoclonal)
MOD_ATT:N-N (__SP__,anti)
COMP:V-N(In) (__NODE__,line)
SUBJ:V-N (__NODE__,decrease)
OBJ:V-N (__NODE__,protein)